Skip to main content
Xvivo Perfusion AB (publ) (XVIPF)
OTCMKTS · Delayed Price · Currency is USD
32.90
0.00 (0.00%)
May 8, 2025, 4:00 PM EDT

Revenue by Product

Fiscal year is January - December.
Fiscal Year
 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Thoracic
384.36M
Log In
Log In
Log In
Log In
Thoracic Growth
29.70%
Log In
Log In
Log In
Log In
Abdominal
134.04M
Log In
Log In
Log In
Log In
Abdominal Growth
89.16%
Log In
Log In
Log In
Log In
Services
79.14M
Log In
Log In
Log In
Log In
Services Growth
64.61%
Log In
Log In
Log In
Log In
All Business except Durable Goods
-
Log In
Log In
Log In
Log In
All Business except Durable Goods Growth
-
Log In
Log In
Log In
Log In
Durable Goods
-
Log In
Log In
Log In
Log In
Durable Goods Growth
-
Log In
Log In
Log In
Log In

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
United States
308.10M
Log In
Log In
Log In
Log In
United States Growth
37.01%
Log In
Log In
Log In
Log In
EMEA Excluding Sweden, Netherlands and Italy
128.28M
Log In
Log In
Log In
Log In
EMEA Excluding Sweden, Netherlands and Italy Growth
32.27%
Log In
Log In
Log In
Log In
Italy
58.93M
Log In
Log In
Log In
Log In
Italy Growth
174.32%
Log In
Log In
Log In
Log In
Asia/Pacific and Oceania
42.18M
Log In
Log In
Log In
Log In
Asia/Pacific and Oceania Growth
124.24%
Log In
Log In
Log In
Log In
Netherlands
30.22M
Log In
Log In
Log In
Log In
Netherlands Growth
16.29%
Log In
Log In
Log In
Log In
North and South America, Excluding the United States
25.62M
Log In
Log In
Log In
Log In
North and South America, Excluding the United States Growth
0.53%
Log In
Log In
Log In
Log In
Sweden
4.22M
Log In
Log In
Log In
Log In
Sweden Growth
152.57%
Log In
Log In
Log In
Log In
Americas
-
Log In
Log In
Log In
Log In
Americas Growth
-
Log In
Log In
Log In
Log In